Raleigh Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5
Closed -$360 773
2024
Q4
$360 Sell
5
-15
-75% -$1.17K ﹤0.01% 966
2024
Q3
$1.63K Sell
20
-213
-91% -$17K ﹤0.01% 839
2024
Q2
$17.3K Buy
233
+5
+2% +$375 0.01% 449
2024
Q1
$17.8K Sell
228
-292
-56% -$21.7K 0.01% 443
2023
Q4
$37.1K Sell
520
-13
-2% -$905 0.02% 317
2023
Q3
$37K Buy
533
+65
+14% +$4.91K 0.02% 297
2023
Q2
$37.9K Buy
468
+172
+58% +$14.1K 0.02% 277
2023
Q1
$23.9K Buy
296
+62
+26% +$4.99K 0.01% 341
2022
Q4
$17.5K Buy
234
+159
+212% +$11.3K 0.01% 341
2022
Q3
$5K Buy
+75
New +$5.2K ﹤0.01% 483

Other funds holding HOLX

Raleigh Capital Management's HOLX Position: Q1 2025 in Review

Raleigh Capital Management sold out of Hologic (HOLX) in Q1 2025, closing a stake of 5 shares — an estimated $360 sold.

Raleigh Capital Management first reported a position in HOLX in Q3 2022 and held it in 10 quarters. The position peaked at $37.9K in Q2 2023. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Raleigh Capital Management reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 5 Hologic shares in Q1 2025, an estimated $360.
  • Raleigh Capital Management first reported a position in Hologic in Q3 2022 and held it in 10 quarters.
  • Raleigh Capital Management's Hologic position peaked at $37.9K in Q2 2023.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.